KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (2019 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Shares Outstanding for 5 consecutive years, with $2.0 billion as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Shares Outstanding rose 19.51% year-over-year to $2.0 billion, compared with a TTM value of $2.0 billion through Jun 2023, up 19.51%, and an annual FY2022 reading of $1.9 billion, up 117312.52% over the prior year.
  • Shares Outstanding was $2.0 billion for Q2 2023 at Ginkgo Bioworks Holdings, up from $1.9 billion in the prior quarter.
  • Across five years, Shares Outstanding topped out at $2.0 billion in Q2 2023 and bottomed at $408497.0 in Q3 2021.
  • Average Shares Outstanding over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2021.
  • The sharpest move saw Shares Outstanding tumbled 99.87% in 2022, then surged 119124.14% in 2023.
  • Year by year, Shares Outstanding stood at $1.3 billion in 2019, then increased by 2.63% to $1.3 billion in 2020, then rose by 25.05% to $1.6 billion in 2021, then grew by 17.41% to $1.9 billion in 2022, then rose by 3.32% to $2.0 billion in 2023.
  • Business Quant data shows Shares Outstanding for DNA at $2.0 billion in Q2 2023, $1.9 billion in Q1 2023, and $1.9 billion in Q4 2022.